Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins and acquisitions, here’s a quick look at which stocks will be ...
The former Kate Middleton was diagnosed with cancer early in 2024, and much speculation about the state of her health has followed. Catherine, Princess of Wales, has since shared that she ...
The trend is also visible in other FMCG companies. Zydus Wellness, the company behind brands like Complan and Glucon-D, is expanding its rural coverage, focusing on increasing penetration where brands ...
Nine chief marketing officer Liana Dubois and Stan chief executive Martin Kugeler will depart the company as it simplifies its leadership structure and streamlines into three divisions ...
Add articles to your saved list and come back to them any time. The chief executive of streaming service Stan will exit the company amid a significant restructure of Nine Entertainment.
The surprise Golden Globe winner tells IndieWire why the industry remains "apprehensive" about his Donald Trump role, and he dishes on new indie projects with Mungiu and Justin Kurzel.
It looks like Captain America: Brave New World will be the first installment in the Marvel Cinematic Universe sub-franchise to not feature Sebastian Stan‘s Bucky Barnes/Winter Soldier.
“Brave the Dark” is based on a true story about the impact Stan Deen had on student Nate Busko (now Nate Deen, after changing his name in honor of Stan Deen). Jared Harris, of “Chernobyl ...
Stanford researchers created MUSK, an AI model that combines medical images and text to improve cancer prognosis and treatment predictions, outperforming traditional methods in accuracy across ...
AI is breaking new ground in cancer care with a revolutionary model that predicts outcomes more accurately than ever before. By combining medical images and text, it outperforms traditional methods, ...
As Sebastian Stan Receives Awards Buzz, He Shared A Sweet Take On How Marvel Has Impacted His Career
The actor once again proves why he's a gem. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. It’s also humbling for me, you know? Because ...
Nomura has upgraded Zydus Lifesciences Ltd. to a 'buy' from its earlier 'neutral' stance, raising the target price to Rs 1,140 from Rs 1,030, implying a potential upside of 16%. Robust earnings growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback